After surgery , women received three cycles of FEC ( fluorouracil @ mg/m ( @ ) plus epirubicin @ mg/m ( @ ) plus cyclophosphamide @ mg/m ( @ ) ) given intravenously every @ weeks , followed by @ weeks of the same assigned neoadjuvant anti-HER@ therapy .